Literature DB >> 25559805

PIK3CA genotype and treatment decisions in human epidermal growth factor receptor 2-positive breast cancer.

David W Cescon1, Philippe L Bedard2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25559805     DOI： 10.1200/JCO.2014.59.3160

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples.

Authors:  Heather Sanders; Kevin Qu; Hairong Li; Lin Ma; Cindy Barlan; Xi Zhang; James Prentice; David Wolfson; Beryl Crossley; Anthony Sferruzza; John Sninsky; David Ross; Andrew Grupe; Joseph Catanese; Feras Hantash; Frederic Waldman
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

2.  Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.

Authors:  Begoña Martin-Castillo; Eugeni Lopez-Bonet; Elisabet Cuyàs; Gemma Viñas; Sonia Pernas; Joan Dorca; Javier A Menendez
Journal:  Oncotarget       Date:  2015-10-20

3.  Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting.

Authors:  Agnieszka Adamczyk; Aleksandra Grela-Wojewoda; Małgorzata Domagała-Haduch; Aleksandra Ambicka; Agnieszka Harazin-Lechowska; Anna Janecka; Ida Cedrych; Kaja Majchrzyk; Anna Kruczak; Janusz Ryś; Joanna Niemiec
Journal:  J Cancer       Date:  2017-01-01       Impact factor: 4.207

4.  MutScan: fast detection and visualization of target mutations by scanning FASTQ data.

Authors:  Shifu Chen; Tanxiao Huang; Tiexiang Wen; Hong Li; Mingyan Xu; Jia Gu
Journal:  BMC Bioinformatics       Date:  2018-01-22       Impact factor: 3.169

5.  Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors.

Authors:  Michael Marotta; Taku Onodera; Jeffrey Johnson; G Thomas Budd; Takaaki Watanabe; Xiaojiang Cui; Armando E Giuliano; Atsushi Niida; Hisashi Tanaka
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

6.  Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.

Authors:  Matthias Christgen; Jana L van Luttikhuizen; Mieke Raap; Peter Braubach; Lars Schmidt; Danny Jonigk; Friedrich Feuerhake; Ulrich Lehmann; Brigitte Schlegelberger; Hans H Kreipe; Doris Steinemann
Journal:  Oncotarget       Date:  2016-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.